Bioline Rx reported $360K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
Bioline Rx USD 360K 84K Sep/2025
Capricor Therapeutics 581K 581K Dec/2024